Fracture Reduction Affects Medicare Economics (FRAME): impact of increased osteoporosis diagnosis and treatment (Q81824618)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15942702%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

title

Fracture Reduction Affects Medicare Economics (FRAME): impact of increased osteoporosis diagnosis and treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15942702%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15942702%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

author name string

Alison B King

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15942702%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

K G Saag

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15942702%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

R T Burge

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15942702%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

M Pisu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15942702%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

publication date

8 June 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15942702%20AND%20SRC:MED&resulttype=core&format=json

Osteoporosis International

12 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15942702%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15942702%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15942702%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

page(s)

1545-1557

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15942702%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00198-005-1869-5

12 January 2020

exact match

0 references

cites work

Recognition of vertebral fracture in a clinical setting

1 reference

12 December 2020

Epidemiology of vertebral fractures in women

1 reference

12 December 2020

A framework for cost-sharing policy analysis

1 reference

12 December 2020

A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group

1 reference

12 December 2020

Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis

1 reference

12 December 2020

Osteoporosis: review of the evidence for prevention, diagnosis and treatment and cost-effectiveness analysis. Introduction

1 reference

12 December 2020

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

1 reference

12 December 2020

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

1 reference

12 December 2020

BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures.

1 reference

12 December 2020

Healthcare use among U.S. women aged 45 and older: total costs and costs for selected postmenopausal health risks.

1 reference

12 December 2020

Methodology for estimating current and future burden of osteoporosis in state populations: application to Florida in 2000 through 2025.

1 reference

12 December 2020

Trends In Medicare Supplemental Insurance And Prescription Drug Coverage, 1996-1999

1 reference

12 December 2020

Screening for osteoporosis in postmenopausal women: recommendations and rationale

1 reference

12 December 2020

Risk of new vertebral fracture in the year following a fracture

1 reference

12 December 2020

Medicare program; revisions to payment policies under the physician fee schedule for calendar year 2005. Final rule with comment period

1 reference

12 December 2020

1 reference

12 December 2020

Screening for osteoporosis and colon cancer under Medicare

1 reference

12 December 2020

Risedronate preserves bone architecture in early postmenopausal women in 1 year as measured by three-dimensional microcomputed tomography

1 reference

12 December 2020

Estimating hip fracture morbidity, mortality and costs

1 reference

12 December 2020

Failure to diagnose and treat osteoporosis in elderly patients hospitalized with hip fracture

1 reference

12 December 2020

Older women with fractures: patients falling through the cracks of guideline-recommended osteoporosis screening and treatment.

1 reference

12 December 2020

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

12 December 2020

Prevalence and incidence of vertebral deformities

1 reference

12 December 2020

Costs and health effects of osteoporotic fractures.

1 reference

12 December 2020

Practice pattern variation in the prevention and treatment of osteoporosis

1 reference

12 December 2020

Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation

1 reference

12 December 2020

Perspective. How many women have osteoporosis?

1 reference

12 December 2020

Risk of hip fracture derived from relative risks: an analysis applied to the population of Sweden.

1 reference

12 December 2020

Medicare program; Medicare coverage of and payment for bone mass measurements--HCFA. Interim final rule with comment period

1 reference

12 December 2020

Mortality and morbidity after hip fractures

1 reference

12 December 2020

Treatment of osteoporosis: are physicians missing an opportunity?

1 reference

12 December 2020

Initiation of osteoporosis treatment after bone mineral density testing

1 reference

12 December 2020

Challenges for model-based economic evaluations of postmenopausal osteoporosis interventions

1 reference

12 December 2020

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

12 December 2020

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

1 reference

12 December 2020

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

1 reference

12 December 2020

Fractures attributable to osteoporosis: report from the National Osteoporosis Foundation

1 reference

12 December 2020

Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment

1 reference

12 December 2020

Low Frequency of Treatment of Osteoporosis Among Postmenopausal Women Following a Fracture

1 reference

12 December 2020

The direct medical costs of osteoporosis for American women aged 45 and older, 1986.

1 reference

12 December 2020

10.1007/S00198-005-1869-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15942702%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1 reference